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Dedicated outpatient vascular access centers (VAC)
specializing in percutaneous interventions (angiography,
thrombectomy, angioplasty and catheter placement) provide
outpatient therapy that can obviate the need for
hospitalization. This paper reports the impact of one VAC
staffed by interventional nephrologists on vascular
access-related hospitalization and missed outpatient dialysis
treatments. We performed a retrospective analysis of vascular
access-related hospitalized days and missed vascular
access-related outpatient dialysis treatments from 1995 to
2002 in 21 Phoenix Arizona Facilities (5928 cumulative
patients) and 1275 cumulative Fresenius Medical Care North
America (FMCNA) facilities (289 454 cumulative patients) to
evaluate the impact of the introduction of a VAC in Phoenix.
Vascular access-related hospitalized days/patient year and
missed dialysis treatments/patient year declined from 1997
to 2002 across all access types. The decline was greater in
Phoenix and coincided with the creation of a VAC in 1998. By
2002, there were 0.57 fewer hospitalized days/patient year
and 0.29 fewer missed treatments/patient year than in the
national sample (Po0.01). In 2002, the relative risk for
vascular access hospitalized days was 0.38 (95% confidence
interval (CI) 0.27–0.5) (Po0.01) and for vascular access-related
missed outpatient dialysis treatments was 0.34 (95% CI
0.24–0.49) (Po0.01) in Phoenix vs FMCNA after adjustment
for age, gender, diabetic status duration of dialysis and
access type. VAC development was associated with a
significant decrease in vascular access-related hospitalization
and missed outpatient dialysis treatments. Further studies
are necessary to demonstrate this effect in other
communities.
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Hemodialysis access failure remains a major source of
morbidity and hospitalization for end stage renal disease
(ESRD) patients. ESRD patients undergo more than one
access procedure per patient year, with annual costs estimated
at greater than $1.5 billion.1 Access failure is second only to
cardiovascular disease as a cause of hospitalization and in
2001 accounted for 40% of ESRD patient hospitalizations.2
The frequent need for emergent procedures strains the
healthcare delivery system and its dialysis facilities, hospitals,
surgical units and interventional radiology suites. Patients
requiring access interventions are frequently placed on
supplemental operating room schedules or have to wait up
to 48–72 h for procedures. This often results in missed dialysis
treatments or catheter placement to allow emergent dialysis.
In recognition of these problems, groups throughout the US
and Europe have explored other delivery models to stream-
line vascular access care.
One approach to improving vascular access intervention
has been the development of dedicated outpatient vascular
access center (VAC).3,4 These centers specialize in percuta-
neous interventions (angiography, thrombectomy, angio-
plasty and catheter placement). Some centers also provide
surgical access creation and revision. Many of the interven-
tionists in these centers are nephrologists who have been
trained in endovascular techniques.5 The safety and efficacy
of the procedures performed in these outpatient centers is
well documented in the literature.6–9 However, there are little
published data on the impact of these centers on vascular
access-related hospitalization, missed dialysis treatments or
the cost of care. The purpose of this paper is to evaluate the
impact of a dedicated outpatient VAC in Phoenix, AZ on
vascular access care delivery, hospitalization and missed
outpatient dialysis treatments.
RESULTS
Phoenix patients were more likely to be older, Caucasian,
diabetic and have AV fistula (AVF) or central venous catheters
(CC) than the national Fresenius Medical Care North
America (FMCNA) cohort (Tables 1 and 2). There was no
significant difference in mean vascular access-related
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hospitalized days per patient year from 1995 to 1997 or mean
missed outpatient hemodialysis treatments per patient year
(1996–1998) between Phoenix (AZ) patients and the national
sample. Vascular access-related hospitalized days per patient
year and missed outpatient hemodialysis treatments per
patient year then gradually declined in both groups. This
decline was greater in the Phoenix area, resulting in
significantly fewer missed vascular access-related FMCNA
outpatient dialysis treatments per patient year and hospita-
lized days per patient year than seen in the national cohort
(Figures 1 and 2). AVF, prevalence increased in Phoenix and
the FMCNA cohort, beginning in 1997 and 1998 and
continuing through 2002. This increase was more pro-
nounced in Phoenix than the national FMCNA cohort
(Table 2). Dialysis catheter use was higher in Phoenix than in
the national cohort throughout the study period. This
difference gradually declined (31.5% catheters in Phoenix
vs 16% nationally in 1995; 30.2% catheters in Phoenix vs
29.3% catheters nationally in 2002) due to a marked increase
in catheter use in the national cohort and a modest decline in
catheter use in Phoenix during this time period (Table 2).
Decreases in hospitalized days and missed vascular access-
related FMCNA outpatient dialysis treatments however were
evident in all access types, but were more pronounced in
Phoenix, resulting in significantly fewer vascular access-
related missed outpatient treatments per patient year and
hospitalized days per patient year for AVF, AV graft, and CC
patients than in the national FMCNA cohort (Table 3). These
changes coincided with the creation of the VAC in 1998 and
accelerated in 2000 with the full accreditation of the
Ambulatory Surgery Center (ASC).
Declines in vascular access-related hospitalization were
also apparent on a facility-specific basis, resulting in 0.64
fewer vascular access-related hospitalized days per patient
year in 2001 and 0.57 fewer vascular access-related hospita-
lized days per patient year in 2002 than in the national
sample (Table 4). Similarly, missed vascular access-related
FMCNA outpatient dialysis treatments per patient year were
significantly lower in Phoenix (AZ) facilities than in the
Table 1 | Patient demographics
Patient demographics
Patient age (Mean7s.d.) % Male gender % Caucasian % Diabetic
Year Phoenix FMCNA P Phoenix FMCNA P Phoenix FMCNA P Phoenix FMCNA P
1995 60.3715.1 58.9715.6 o0.01 51.7 51.5 NS 73.7 56.4 o0.01 50.6 44.7 o0.01
1996 60.9715.1 59.2715.6 o0.01 52.0 51.5 NS 78.0 56.7 o0.01 52.1 46.6 o0.01
1997 61.3714.9 59.5715.5 o0.01 51.4 51.8 NS 80.8 56.8 o0.01 52.7 48.3 o0.01
1998 60.9715.4 59.9715.5 o0.01 51.6 52.2 NS 84.0 56.9 o0.01 54.4 49.6 o0.01
1999 61.4715.2 60.2715.6 o0.01 54.8 52.7 NS 86.1 57.2 o0.01 54.9 50.6 o0.01
2000 62.2715.4 60.4715.5 o0.01 55.0 52.9 NS 86.1 56.4 o0.01 55.6 51.7 o0.01
2001 62.5715.2 60.6715.5 o0.01 55.6 53.2 o0.05 86.8 56.5 o0.01 57.6 53.3 o0.01
2002 62.2715.2 60.8715.5 o0.01 57.4 53.4 o0.01 89.0 56.8 o0.01 56.7 54.4 o0.05
NS, not significant.
Table 2 | Access type (%)
Access type (%)
Phoenix FMCNA
Year
AV
fistula
AV
graft
Central
catheter
AV
fistula
AV
graft
Central
catheter P
1995 24.1 44.4 31.5 22.4 61.6 16.0 o0.01
1996 23.6 40.3 36.0 21.5 58.7 19.8 o0.01
1997 25.0 39.7 35.3 21.5 55.9 22.5 o0.01
1998 26.7 41.3 32.1 22.8 52.3 25.0 o0.01
1999 29.6 41.9 28.5 24.5 48.7 26.9 o0.01
2000 32.6 37.1 30.3 27.0 45.2 27.8 o0.01
2001 37.2 32.4 30.4 29.3 41.7 28.9 o0.01
2002 40.7 29.1 30.2 31.5 39.1 29.3 o0.01
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Figure 1 | Vascular access-related hospital days per patient-year.
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Figure 2 | Vascular access-related missed dialysis treatments per
patient-year.
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national sample (0.31 fewer missed treatments/patient year in
2001 and 0.29 fewer missed treatments/patient year in 2002)
(Table 5). Poisson models demonstrated a markedly lower
relative risk of experiencing vascular access-related hospital
days and vascular access-related missed outpatient dialysis
treatments in Phoenix compared to the FMCNA sample in
both the unadjusted and adjusted models (adjusted for age,
gender, diabetic status, duration of dialysis, and dialysis
access type). These declines began in 1998–2000 and increased
significantly in 2001 and 2002. By 2002 the relative risk for
vascular access-related hospital days was 0.4 (95% confidence
interval (CI) 0.29–54) (unadjusted model) and 0.38 (95% CI
0.27–0.5) (adjusted model) and the relative risk for missed
vascular access-related FMCNA outpatient dialysis treatments
was 0.37 (95% CI 0.27–0.51) (unadjusted model) and 0.34
(95% CI 0.24–0.49) (adjusted model) in Phoenix compared
to the FMCNA national cohort (Po0.01) (Tables 6 and 7).
DISCUSSION
Arizona Kidney Disease and Hypertension Center (AKDHC),
a large nephrology practice in Phoenix, Arizona, started
operating a VAC within the walls of a hospital in 1998. In
January 2000, the practice opened an Ambulatory Surgery
Center (ASC) focused on the creation and maintenance of
vascular access for hemodialysis patients. The center
primarily serves the patients in Fresenius Dialysis facilities
in the metro Phoenix area and some rural areas of Arizona,
and is the provider of choice for vascular access intervention
for all AKDHC patients in the FMCNA units in Arizona. Two
nephrologists were trained as interventionists and they
perform the procedures. A vascular surgeon within the group
creates and modifies the accesses. The physicians of AKDHC
are also the medical directors for FMCNA in the state of
Arizona, and are responsible for quality oversight in these
facilities.
Prior to the operation of the VAC in 1998, referrals for
vascular access care were dispersed among several hospitals
and several different interventionists and surgeons within the
Phoenix metropolitan area. This was largely determined by
insurance requirements and, as a result, referral patterns
changed frequently. Focus and comprehensive access care
were often lacking. It was not unusual that a given hospital
might not have a competent interventionist on staff. The VAC
was initially constructed within the walls of an existing
hospital. This step improved the ability to obtain focused
care for many patients’ vascular access problems. Barriers still
Table 3 | Vascular access-related hospitalized days and
vascular access-related missed dialysis treatment with
breakdown by access type
Overall hosp.
days/patient-year
Overall missed
rx/patient-year
Calendar year Phoenix FMCNA P-value Phoenix FMCNA P-value
AV fistula patients
1995 0.62 0.64 NS 0.2 0.28 o0.05
1996 0.77 0.56 o0.01 0.32 0.26 NS
1997 0.48 0.59 o0.05 0.18 0.27 o0.01
1998 0.41 0.5 o0.05 0.17 0.24 o0.05
1999 0.23 0.53 o0.01 0.12 0.25 o0.01
2000 0.6 0.51 o0.05 0.25 0.24 NS
2001 0.12 0.43 o0.01 0.06 0.2 o0.01
2002 0.09 0.45 o0.01 0.04 0.21 o0.01
AV graft patients
1995 1.71 1.94 o0.01 0.66 0.9 o0.01
1996 1.66 1.8 NS 0.81 0.85 NS
1997 2.03 1.59 o0.01 0.94 0.76 o0.01
1998 1.05 1.34 o0.01 0.56 0.63 NS
1999 1.08 1.31 o0.01 0.46 0.62 o0.01
2000 0.75 1.27 o0.01 0.36 0.58 o0.01
2001 0.49 1.11 o0.01 0.2 0.52 o0.01
2002 0.32 1.05 o0.01 0.14 0.49 o0.01
Catheter patients
1995 2.23 3.52 o0.01 1.08 1.65 o0.01
1996 2.41 3.07 o0.01 1.11 1.47 o0.01
1997 2.73 2.95 o0.05 1.26 1.37 NS
1998 1.52 2.5 o0.01 0.74 1.17 o0.01
1999 1.58 2.41 o0.01 0.67 1.12 o0.01
2000 1.56 2.29 o0.01 0.69 1.07 o0.01
2001 0.77 2.03 o0.01 0.34 0.92 o0.01
2002 0.83 1.96 o0.01 0.38 0.92 o0.01
NS, not significant.
Table 4 | Vascular access-related hospitalized days per
patient-year
VA hospitalization days per patient-year
Phoenix FMCNA
Calendar year N Fac Mean7s.d. N Fac Mean7s.d. P-value
1995 13 1.4470.94 492 1.9871.76 0.0689**
1996 13 1.5770.91 540 1.9772.49 0.1590**
1997 15 1.6271.02 621 1.8271.65 0.4907**
1998 14 1.1370.63 695 1.5471.51 0.0325
1999 14 0.9370.74 757 1.4871.67 0.0165
2000 16 0.9270.85 836 1.3571.44 0.0684**
2001 17 0.5570.52 932 1.1971.28 o0.01
2002 17 0.5770.49 989 1.1471.30 o0.01
**P-value40.05 means that the means in two populations are not significantly
different at 0.05 significance level.
Table 5 | Vascular access related missed dialysis treatments
per patient-year
VA missed treatments per patient-year
Phoenix FMCNA
Calendar year N Fac Mean7s.d. N Fac Mean7s.d. P-value
1995 13 0.5870.45 492 0.9570.88 0.0689**
1996 13 0.7870.51 540 0.9370.85 0.1590**
1997 15 0.7870.52 621 0.8870.83 0.4907**
1998 14 0.5770.42 695 0.7370.71 0.0325
1999 14 0.4670.32 757 0.6970.74 0.0165
2000 16 0.4570.43 836 0.6470.72 0.0684**
2001 17 0.2670.24 932 0.5770.64 o0.01
2002 17 0.2670.23 989 0.5570.67 o0.01
**P-value40.05 means that the means in two populations are not significantly
different at 0.05 significance level.
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existed because the hospital in which the center resided did
not participate in all available healthcare plans and, therefore,
focused care was unavailable for many patients. Since the
accreditation of the ASC, limitations due to insurance
coverage have largely been eliminated. As the ASC is owned
by the AKDHC practice, contracts with third party payors are
usually negotiated to include physician services as well as
ASC facility services. In some instances, ‘carve out’ contracts
with third party payors have been negotiated to accommo-
date vascular access care within the ASC.
The data reflecting the Phoenix VAC experience represent
the first published data to specifically address the impact of a
VAC on hospitalization and missed outpatient dialysis
treatments. The demonstrated reductions of approximately
40.6 hospital days/patient year and decreased missed
treatments of 40.3/patient year represent the effects of
intense focused vascular access care in a large metropolitan
area as well as rural areas of Arizona. It also illustrates the
impact of coordinated access care provided by interventional
nephrologists initially in a hospital-based VAC and sub-
sequently in an ASC. This coordination of care is facilitated
by the dual responsibilities of the nephrologists as medical
directors of the FMCNA dialysis facilities and as interven-
tionists in the VAC.
The reported decrease in missed vascular access related
FMCNA outpatient dialysis treatments and hospitalization
across all access types has a profound potential impact on
clinical outcomes and the cost of dialysis care. Missed dialysis
treatments result in a significant increase in mortality risk
(14% increase in the relative mortality risk from one missed
treatment/month).10 The reduction of 0.6 hospital day per
patient per year represents a potential savings of approxi-
mately $ 300 million to $750 million per year when applied
across 250 000 hemodialysis patients, assuming $2000–5000
expenses per hospital day. Outpatient vascular placement is
vastly less expensive (up to $9000 less per procedure) than
inpatient surgery or surgery performed in the hospital
outpatient setting under the Hospital Outpatient Prospective
Payment System. Similarly, other outpatient access proce-
dures such as thrombectomy and angioplasty are much less
costly in ASC than in the hospital inpatient or outpatient
setting.11,12 Unfortunately, the majority of hemodialysis
patients in the United States do not have vascular access
care provided in this manner.
The FMC-NA outcomes likely represent values that might
be expected in most areas of the US. The demonstrated
decrease in hospitalization and missed outpatient dialysis
treatments associated with introduction of a VAC represents
an opportunity to improve clinical outcomes, while decreas-
ing the cost of access-related complications. It is also clear
evidence of the potential to improve vascular access care
when nephrologists assume the prime responsibility for
Table 6 | Poisson models of vascular access-related hospitalized days (Phoenix vs FMCNA)
Unadjusted model Adjusteda model
95% CI 95% CI
Relative risk
(ref. FMCNA=1.0) LL UL P-value
Relative risk
(ref. FMCNA=1.0) LL UL P-value
1995 0.89 0.69 1.14 0.36 0.91 0.69 1.21 0.52
1996 1.07 0.84 1.36 0.58 0.93 0.71 1.22 0.60
1997 1.47 1.16 1.86 o0.01 1.42 1.08 1.86 0.01
1998 0.71 0.55 0.92 0.01 0.62 0.46 0.84 o0.01
1999 0.72 0.56 0.93 0.01 0.64 0.48 0.86 o0.01
2000 0.70 0.53 0.92 0.01 0.86 0.64 1.17 0.35
2001 0.37 0.27 0.49 o0.01 0.38 0.27 0.53 o0.01
2002 0.40 0.29 0.54 o0.01 0.38 0.27 0.53 o0.01
aAdjusted variables: age, gender, race, diabetes status, duration of dialysis and dialysis access.
LL, lower level; UL, upper level.
Table 7 | Poisson models of vascular access-related missed dialysis treatments (phoenix vs FMCNA)
Unadjusted model Adjusteda model
95% CI 95% CI
Relative risk
(ref. FMC) LL UL P-value
Relative risk
(ref. FMC) LL UL P-value
1995 0.74 0.58 0.95 0.02 0.67 0.51 0.88 o0.01
1996 0.87 0.69 1.09 0.24 0.82 0.64 1.07 0.14
1997 1.21 0.96 1.52 0.11 1.13 0.87 1.46 0.36
1998 0.76 0.59 0.97 0.03 0.64 0.48 0.85 o0.01
1999 0.68 0.53 0.88 o0.01 0.64 0.48 0.84 o0.01
2000 0.69 0.53 0.90 0.01 0.83 0.61 1.12 0.22
2001 0.33 0.25 0.45 o0.01 0.36 0.26 0.50 o0.01
2002 0.37 0.27 0.51 o0.01 0.34 0.24 0.49 o0.01
aAdjusted variables: age, gender, race, diabetes status, duration of dialysis and dialysis access.
LL, lower level; UL, upper level.
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vascular access management. Some of the demonstrated
decrease in hospitalization and missed vascular access-related
FMCNA outpatient dialysis treatments may be attributable to
increases in the rates of AVF prevalence in Phoenix.13,14 This
in itself is a laudable accomplishment15,16 and does not
negate the role of the VAC. The Phoenix center was utilized
to coordinate an AVF creation program based on preopera-
tive imaging and outpatient AVF creation by a dedicated
vascular surgeon. It is also used to evaluate and correct
problems resulting in poorly maturing AVFs. Significant
decreases in vascular access-related hospitalization and
missed outpatient hemodialysis treatments, however, were
seen in AVF, AV graft and catheter patients. By 2002, there
was a 62% lower relative risk of vascular access hospitalized
days and a 66% lower risk of vascular access-related missed
treatments in Phoenix compared to the FMCNA national
cohort, despite adjustments for age, gender, diabetic status
duration of dialysis, and access type. This impact across the
full spectrum of dialysis access and patient demographics
points to the effect of improvements in vascular access care
delivery rather than only a change in the relative prevalence
of AVF and CCs.
Vascular access-related hospitalization and missed out-
patient dialysis treatments also declined in the FMCNA
national cohort, although less so than in Phoenix. We believe
that these changes in the control group reflect the results of
K/Dialysis Outcome Quality Initiative17-driven increased
national interest in vascular access outcomes and the national
trend toward the use of percutaneous interventions for access
failure.1 Increased attention and focus on vascular access
(Hawthorne effect) that coincided with creation of the VAC
likely accounted for some of the reported improvements.
These improvements also may have been accomplished
through focused efforts using other models, including
hospital-based programs or programs led by an interven-
tional radiologist or vascular surgeon in conjunction with a
nephrology group. These data however show that the creation
of a VAC with care provided by interventional nephrologists
is one route for decreasing vascular access-related hospita-
lization. The fact that these types of improvements have not
frequently been reported in other communities suggests that
the development of a dedicated VAC is an important element
that can catalyze and deliver improved vascular access care.
The data also reveal a continued reliance on catheters for
access in approximately 30% of the population. This is
similar to the national data and highlights the need for
further efforts to replace catheters with alternative access
both in Phoenix and nationally.
This paper has several limitations. This paper reports data
on missed vascular access-related FMCNA outpatient dialysis
treatments, vascular access-related hospital admissions and
hospitalized days, and does not include thrombosis and
procedure rates. It is possible that the decline in hospital
admissions and hospitalized days masks an increase in
procedure rates. Although there is no evidence to suggest
an increase in procedure rates or thrombosis, the available
data do not allow us to make a definitive statement. This is an
important question that will require a future study
specifically designed to address these questions. Despite this
limitation, we believe that the decline in hospitalization and
missed outpatient treatments has significant potential
benefits. These data also cannot rule out the possibility of
other potential confounding factors such as the role of
managed care. However, this appears unlikely due to the
diminished role of managed care programs over the past 5–8
years and the preponderance of Medicare patients in the
overall population (both in Phoenix and nationally). The
unusually high number of hospital days for the AVF group
in Phoenix in 2000 remains unexplained. Review of the
data however revealed that three patients each accounted for
over 30 hospital days, and together those three patients
accounted for 124 of 188 (66%) of the Phoenix group’s
hospital days (data not shown). Lastly, no formal claims
analysis was performed. Further studies including
formal claims analysis are necessary to further clarify the
financial ramifications of the development and use of
outpatient VACs.
In conclusion, the development of a dedicated VAC staffed
by interventional nephrologists was associated with a
significant decrease in vascular access-related hospitalizations
and vascular access-related FMCNA missed outpatient
dialysis treatments across all access types. These data
represent the experience at one center in one region of the
US. Further studies reporting the clinical and economic
impact of VACs in other regions are necessary to demonstrate
the wider applicability of this approach.
MATERIALS AND METHODS
We performed a retrospective analysis of vascular access-related
hospitalizations, hospitalized days and missed outpatient dialysis
treatments from 1995 to 2002 for all FMC Dialysis facilities in the
Phoenix (Arizona area) as well as all FMCNA dialysis units within
the US. This included data from 21 Arizona Facilities (5928
cumulative patients) and 1275 cumulative FMCNA facilities
(289 454 cumulative patients). Data were obtained from the
FMCNA Data Warehouse. This database captures patient demo-
graphics and outcomes including all patient hospitalizations,
hospitalized days and missed outpatient dialysis treatments, defined
as treatments that were not performed as scheduled in a FMC
outpatient dialysis facility. International Classification of Diseases
(ICD)-9 codes are entered by dialysis unit personnel to identify the
cause of admissions or missed dialysis treatments.
Missed outpatient dialysis treatments were defined as outpatient
dialysis treatments that were not performed as scheduled in a
FMCNA outpatient dialysis facility due to vascular access-related
complications as defined by specific ICD-9 codes. All missed
hemodialysis treatments, whether expected (e.g., because of
hospitalization) or unexpected (e.g., because of noncompliance),
and all permanent discharges (e.g., because of transplantation or
death), together with diagnoses coded according to the ICD, Ninth
Revision, Clinical Modification, were recorded to complete the daily
reconciliation of prescribed and administered treatments. These
required fields must be completed upon the patients’ return in order
for outpatient dialysis to be performed.
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The following primary and secondary diagnostic codes were
utilized to identify vascular access-related hospitalizations and missed
outpatient dialysis treatments: ICD-9 codes 996.1, 996.3, 996.6,
996.62, 996.7, 996.73, 996.74 and 997.2. The numbers of missed
outpatient dialysis treatments per patient-year and hospitalized days
per patient-year were computed for the Phoenix Arizona area and
compared to the national FMCNA cohort. Statistical analysis was
performed using SAS 9.1; SAS Institute, Cary, NC, USA. Data were
expressed as mean7s.d. Parametric (t-test) and nonparametric tests
(Wilcoxon’s test) were used. Poisson analyses of vascular access-
related hospital length of stay and missed dialysis treatments were
performed using PROC GENMOD (SAS 9.1; SAS Institute, Cary,
NC, USA). A P-value lower than 0.05 was considered significant.
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